Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsRECTALStandard

MIGERGOT

CAFFEINE; ERGOTAMINE TARTRATE

Standard Dose
100MG;2MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview MIGERGOT is listed in Drugs@FDA under application 086557 (ANDA).

Marketing status: Prescription Active ingredient CAFFEINE; ERGOTAMINE TARTRATE Form and strength SUPPOSITORY;RECTAL - 100MG;2MG Sponsor COSETTE Submission history Latest submission status date: 2012-11-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview MIGERGOT is listed in Drugs@FDA under application 086557 (ANDA). Marketing status: Prescription Active ingredient CAFFEINE; ERGOTAMINE TARTRATE Form and strength SUPPOSITORY;RECTAL - 100MG;2MG Sponsor COSETTE Submission history Latest submission status date: 2012-11-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.